D-dimer level in COVID-19 infection: a systematic review. Issue 11 (1st November 2020)

• Record Type: Journal Article
• Authors: Rostami, Mehrdad; Mansouritorghabeh, Hassan
• Is Part Of: Expert review of hematology. Volume 13:Issue 11(2020)
• Page Start: 1265
• Page End: 1275
• Publication Date: 2020-11-01
• Subjects: COVID-19 -- coronavirus -- D-dimer -- coagulopathy -- SARS-CoV-2; Hematology -- Periodicals; 616.15005
• DOI: 10.1080/17474086.2020.1831383
• Languages: English
• ISSNs: 1747-4086

Abstract

ABSTRACT: Introduction: COVID-19 disease has spread worldwide from December 2019 to the present day; the early stage of this disease can be associated with high D-dimer, prolonged PT, and elevated levels of fibrinogen, indicating activation of coagulation pathways and thrombosis. In this article, we analyze the levels of D-dimer in patients with COVID-19. Area covered: In the current study, three databases, PubMed, Scopus, Web of Science, searched using related keywords and information extracted from articles such as location, sample size, gender, age, coagulation test values, patient results, and disease severity. Expert opinion: D-dimer level is one of the measures used in patients to detect thrombosis. Studies have reported an increase in D-dimer and fibrinogen concentrations in the early stages of COVID-19 disease a 3 to 4-fold rise in D-dimer levels is linked to poor prognosis. In addition, underlying diseases such as diabetes, cancer, stroke, and pregnancy may trigger an increase in D-dimer levels in COVID-19 patients. Measuring the level of D-dimer and coagulation parameters from the early stage of the disease can also be useful in controlling and managing of COVID-19 disease.